InvestorsHub Logo
Followers 204
Posts 9820
Boards Moderated 6
Alias Born 10/02/2010

Re: laraz5 post# 18232

Sunday, 08/19/2018 2:55:12 AM

Sunday, August 19, 2018 2:55:12 AM

Post# of 21373
LOL, laraz…

I looked at Sherry. This has already been covered.

Sherry Grisewoods was a BOD member of a public company that secured almost $20,000,000 in government grants for a publically traded company before joining the ONCX BOD.

From their (TPIV) filings…

"...Two of our clinical studies are expected to be funded by a total of $17.1 million of grants made by the DOD to the Mayo Clinic. Our collaborators at Mayo Clinic announced a $3.8 million grant which we expect would fully fund a Phase II clinical trial in DCIS that we had planned for our HER2/neu+ vaccine…"

It looks like Sherry Grisewoods may have experience in securing non dilutive financing in the form of grants.

That is outstanding for current ONCX shareholders.

According to ONCX management, the DOD has already provided an early initial round of grants along with the Susan G. Komen Foundation.

It destroys the assumption that ONCX will need to dilute shareholders to secure additional funding.

With an ONCX PPS of $ .018, and an O/S of 105M, we have a market cap of just short of $2,000,000.

That is compared to a market cap of roughly $100,000,000 from her other company.

FWIW, this is the market capitalization target that I have been predicting, as well as ONCX in their presentations.

With a current ONCX market cap of just $2,000,000, based on latest public information, we are looking at a potential gain of 5000%, just to get to a reasonable market valuation of $100,000,000 for a public company that is engaged in FDA clinical trials for Cancer treatment.

Heck, I have seen and am seeing market caps of $300-$500M for MJ stocks that lack the same potential as ONCX.

Hope that helps.

Smile ONCXers, huge potential gains are coming soon.


(Apologies for the ninja edits.)

LOL, IMO and FWIW.

Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.